查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598451

組織工程皮膚替代品市場：按產品、應用和最終用途 - 2025-2030 年全球預測

Tissue Engineered Skin Substitutes Market by Product (Biological, Biosynthetic, Synthetic), Application (Acute Wounds, Chronic Wounds), End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年組織工程皮膚替代品市場價值為11.2億美元，預計到2024年將達到12.5億美元，複合年成長率為12.65%，到2030年將達到25.8億美元，預計將達到1000萬美元。

組織工程皮膚替代品是再生醫學中一個充滿活力的領域，為因燒燙傷、慢性傷口或手術重組需要皮膚更換的人提供先進的解決方案。這些替代品的範圍包括合成的、生物合成的和活的皮膚結構，它們整合了生物或合成材料、促進癒合並與患者的組織整合。慢性傷口和燒傷的增加、人口老化以及生物技術的進步推動了對這些產品的需求，這些進步使得更有效和永續的治療成為可能。應用範圍已擴展到傷口護理、皮膚科和整形外科等醫療領域，透過減少復健時間和改善患者治療效果，使醫療保健系統受益匪淺。最終用途包括醫院、燒燙傷中心和長期照護機構，這些替代品可以挽救生命。

主要市場統計
基準年[2023] 11.2億美元
預計年份 [2024] 12.5億美元
預測年份 [2030] 25.8億美元
複合年成長率（%） 12.65%

市場成長受到 3D 生物列印等技術創新和生物材料進步的影響，這些創新提高了產品功效和對個別患者需求的適應性。研發投資的增加將進一步支持市場擴張，而對先進治療的監管支持代表著一個重大的商機。然而，市場成長面臨著高成本、複雜的製造流程和嚴格的監管要求的挑戰。患者和醫療保健提供者對新技術的認知較低也限制了市場潛力。

透過與研究機構合作，創新混合產品，將細胞技術與合成基質結合以實現更強大的功能，從而擴大應用範圍。探索降低成本策略和可擴展的製造方法可以增加市場准入。創新還可以集中於開發具有增強監測能力的產品，並與數位健康技術相結合，以在治療過程中提供即時回饋。解決技術和經濟障礙的多方面方法可以釋放市場的巨大潛力。競爭格局仍然充滿活力，對於那些擁抱前沿研究和致力於卓越監管的公司來說，機會是存在的。對個人化醫療的關注，利用基因和生物列印技術來提供針對患者的治療，代表了這個高度專業化市場未來成長的一條有希望的道路。

市場動態：快速發展的組織工程皮膚替代品市場的關鍵市場洞察

供需的動態交互作用正在改變組織工程皮膚替代品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 急性和慢性傷口增加
    • 植皮需求增加
    • 皮膚修復技術的進步
  • 市場限制因素
    • 皮膚附屬器再生能力的極限
  • 市場機會
    • 醫療保健領域的技術進步與研發投資
    • 公私部門合作以提高市場滲透率
  • 市場挑戰
    • 缺乏保險報銷政策

波特的五力：駕馭組織工程皮膚替代品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解組織工程皮膚替代品市場的外部影響

外部宏觀環境因素在塑造組織工程皮膚替代品市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 利用組織工程了解皮膚替代品市場的競爭狀況

組織工程皮膚替代品市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質組織工程皮膚替代品市場供應商績效評估

FPNV 定位矩陣是評估組織工程皮膚替代品市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

透過策略分析和組織工程建議，繪製皮膚替代品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對組織工程皮膚替代品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 急性和慢性傷口的發生率增加
      • 植皮需求增加
      • 皮膚修復技術的進步
    • 抑制因素
      • 皮膚附屬器再生能力有限
    • 機會
      • 醫療保健領域的技術進步與研發投資
      • 公私合營推動並擴大市場滲透
    • 任務
      • 缺乏支持性報銷政策
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章組織工程皮膚替代品市場：依產品

  • 生物
  • 生物合成
  • 合成

第7章組織工程皮膚替代品市場：依應用

  • 急性傷口
    • 燒燙傷
    • 手術與創傷
  • 慢性傷口
    • 糖尿病足潰瘍
    • 其他慢性傷口
    • 褥瘡
    • 腿部靜脈性潰瘍

第8章組織工程皮膚替代品市場：依最終用途

  • 醫院
  • 創傷護理中心

第9章組織工程的美洲皮膚替代品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區組織工程皮膚替代品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲組織工程皮膚替代品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Bayer AG
  • Beckman Coulter, Inc.
  • Convatec Group PLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KCI Licensing, Inc.
  • Mallinckrodt PLC
  • Medline Industries, Inc
  • Medtronic PLC
  • Merck KGaA
  • MiMedx Group Inc.
  • Novartis AG
  • Organogenesis, Inc.
  • Regenicin, Inc.
  • Sanofi SA
  • Smith & Nephew PLC
  • The 3M Company
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-0360AB17E196

The Tissue Engineered Skin Substitutes Market was valued at USD 1.12 billion in 2023, expected to reach USD 1.25 billion in 2024, and is projected to grow at a CAGR of 12.65%, to USD 2.58 billion by 2030.

Tissue engineered skin substitutes represent a dynamic sector within regenerative medicine, offering advanced solutions for individuals requiring skin replacement due to burns, chronic wounds, or surgical reconstruction. The scope of these substitutes includes synthetic, biosynthetic, and living skin constructs that integrate biological or synthetic materials, promoting healing and integration with the patient's tissue. The necessity for these products is driven by a growing prevalence of chronic wounds and burn injuries, an aging population, and advancements in biotechnology that enable more effective and sustainable treatments. Applications extend across medical fields, including wound care, dermatology, and plastic surgery, significantly benefiting healthcare systems by reducing recovery times and improving patient outcomes. End-use includes hospitals, burn centers, and long-term care facilities, where such substitutes can be life-saving.

KEY MARKET STATISTICS
Base Year [2023] USD 1.12 billion
Estimated Year [2024] USD 1.25 billion
Forecast Year [2030] USD 2.58 billion
CAGR (%) 12.65%

Market growth is influenced by technological innovations like 3D bioprinting and biomaterial advancements, which enhance product efficacy and adaptability to individual patient needs. Increased investment in research and development further propels market expansion, while regulatory support for advanced therapies offers significant opportunities. However, market growth is challenged by high costs, complex manufacturing processes, and stringent regulatory requirements. Limited awareness among patients and healthcare providers regarding newer technologies also restricts market potential.

Opportunities lie in expanding applications through partnerships with research institutions to innovate hybrid products that combine cellular technology with synthetic matrices for better functionality. The exploration of cost-reduction strategies and scalable manufacturing could enhance market accessibility. Innovation could also focus on developing products with enhanced monitoring capabilities or integrating with digital health technologies for real-time feedback during treatment. A multi-faceted approach addressing both technical and economic barriers can unlock substantial market potential. The competitive landscape remains dynamic, with opportunities for those embracing cutting-edge research and a commitment to regulatory excellence. Focus on personalized medicine, leveraging patient-specific treatments through genetic and bioprinting technologies, represents a promising avenue for future growth in this highly specialized market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Engineered Skin Substitutes Market

The Tissue Engineered Skin Substitutes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of acute and chronic wounds
    • Increased demand for skin grafts
    • Advances in skin regeneration technology
  • Market Restraints
    • Limited ability to reproduce skin appendages
  • Market Opportunities
    • Technological advancements and R&D investment in healthcare
    • Public-private alliance to promote and increase penetration in market
  • Market Challenges
    • Lack of supportive reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Engineered Skin Substitutes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Engineered Skin Substitutes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Engineered Skin Substitutes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Engineered Skin Substitutes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Engineered Skin Substitutes Market

A detailed market share analysis in the Tissue Engineered Skin Substitutes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Engineered Skin Substitutes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Engineered Skin Substitutes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Engineered Skin Substitutes Market

A strategic analysis of the Tissue Engineered Skin Substitutes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Engineered Skin Substitutes Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Beckman Coulter, Inc., Convatec Group PLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KCI Licensing, Inc., Mallinckrodt PLC, Medline Industries, Inc, Medtronic PLC, Merck KGaA, MiMedx Group Inc., Novartis AG, Organogenesis, Inc., Regenicin, Inc., Sanofi S.A., Smith & Nephew PLC, The 3M Company, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Engineered Skin Substitutes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Biological, Biosynthetic, and Synthetic.
  • Based on Application, market is studied across Acute Wounds and Chronic Wounds. The Acute Wounds is further studied across Burn Injuries and Surgery & Trauma. The Chronic Wounds is further studied across Diabetic Foot Ulcers, Other Chronic Wounds, Pressure Ulcers, and Venous Leg Ulcers.
  • Based on End Use, market is studied across Hospitals and Wound Care Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of acute and chronic wounds
      • 5.1.1.2. Increased demand for skin grafts
      • 5.1.1.3. Advances in skin regeneration technology
    • 5.1.2. Restraints
      • 5.1.2.1. Limited ability to reproduce skin appendages
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and R&D investment in healthcare
      • 5.1.3.2. Public-private alliance to promote and increase penetration in market
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of supportive reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Engineered Skin Substitutes Market, by Product

  • 6.1. Introduction
  • 6.2. Biological
  • 6.3. Biosynthetic
  • 6.4. Synthetic

7. Tissue Engineered Skin Substitutes Market, by Application

  • 7.1. Introduction
  • 7.2. Acute Wounds
    • 7.2.1. Burn Injuries
    • 7.2.2. Surgery & Trauma
  • 7.3. Chronic Wounds
    • 7.3.1. Diabetic Foot Ulcers
    • 7.3.2. Other Chronic Wounds
    • 7.3.3. Pressure Ulcers
    • 7.3.4. Venous Leg Ulcers

8. Tissue Engineered Skin Substitutes Market, by End Use

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Wound Care Centers

9. Americas Tissue Engineered Skin Substitutes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Engineered Skin Substitutes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Engineered Skin Substitutes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. Beckman Coulter, Inc.
  • 3. Convatec Group PLC
  • 4. Integra LifeSciences Corporation
  • 5. Johnson & Johnson Services, Inc.
  • 6. KCI Licensing, Inc.
  • 7. Mallinckrodt PLC
  • 8. Medline Industries, Inc
  • 9. Medtronic PLC
  • 10. Merck KGaA
  • 11. MiMedx Group Inc.
  • 12. Novartis AG
  • 13. Organogenesis, Inc.
  • 14. Regenicin, Inc.
  • 15. Sanofi S.A.
  • 16. Smith & Nephew PLC
  • 17. The 3M Company
  • 18. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOSYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BURN INJURIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SURGERY & TRAUMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY OTHER CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY VENOUS LEG ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY WOUND CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 234. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2023